Shanghai Jemincare Pharmaceuticals patents new androgen receptor antagonists
April 25, 2024
Shanghai Jemincare Pharmaceuticals Co. Ltd. has disclosed phosphorus-containing compounds acting as androgen receptor antagonists reported to be useful for the treatment of cancer, alopecia, acne, hirsutism and more.